Literature DB >> 9241247

Androgen receptor-associated protein complex binds upstream of the androgen-responsive elements in the promoters of human prostate-specific antigen and kallikrein 2 genes.

Z Sun1, J Pan, S P Balk.   

Abstract

An increasing number of proteins which bind to hormone-dependent nuclear receptors and mediate their effects on gene expression are being identified. The human prostate-specific antigen (PSA) and kallikrein 2 (KLK2) genes are regulated by the androgen receptor (AR). Using electrophoresis mobility shift assays (EMSA), a common nuclear protein(s) which binds upstream of the androgen-responsive elements (AREs) in the PSA and KLK2 promoters was identified. Binding occurred between bp -539 and -399 and bp -349 and -224 in the PSA and KLK2 promoters respectively, which were shown previously to be necessary for AR-mediated transactivation. Glutathione S-transferase (GST)-AR fusion proteins were constructed to determine whether the AR interacted directly with this protein or protein complex. Specific interactions were observed with AR fusion proteins containing the DNA binding domain. EMSA supershift experiments and GST-AR pull-down experiments followed by Western blotting identified a Fos-related protein(s) of approximately 40 kDa as part of this complex. Competition experiments with a double-stranded oligonucleotide containing an AP-1 binding site demonstrated that DNA binding was not mediated by AP-1. These results indicate that a Fos-containing protein complex distinct from AP-1 binds upstream of the AREs in the PSA and KLK2 promoters, interacts with the AR and may participate in regulation of these two androgen-responsive genes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241247      PMCID: PMC146870          DOI: 10.1093/nar/25.16.3318

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

Review 1.  Nuclear proto-oncogenes fos and jun.

Authors:  L J Ransone; I M Verma
Journal:  Annu Rev Cell Biol       Date:  1990

Review 2.  Joints in the regulatory lattice: composite regulation by steroid receptor-AP1 complexes.

Authors:  J N Miner; M I Diamond; K R Yamamoto
Journal:  Cell Growth Differ       Date:  1991-10

3.  The promoter of the prostate-specific antigen gene contains a functional androgen responsive element.

Authors:  P H Riegman; R J Vlietstra; J A van der Korput; A O Brinkmann; J Trapman
Journal:  Mol Endocrinol       Date:  1991-12

4.  Characterization of the gene for prostate-specific antigen, a human glandular kallikrein.

Authors:  A Lundwall
Journal:  Biochem Biophys Res Commun       Date:  1989-06-30       Impact factor: 3.575

5.  Isolation and characterization of fra-2, an additional member of the fos gene family.

Authors:  H Nishina; H Sato; T Suzuki; M Sato; H Iba
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone.

Authors:  C Jonat; H J Rahmsdorf; K K Park; A C Cato; S Gebel; H Ponta; P Herrlich
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

7.  Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

Authors:  H F Yang-Yen; J C Chambard; Y L Sun; T Smeal; T J Schmidt; J Drouin; M Karin
Journal:  Cell       Date:  1990-09-21       Impact factor: 41.582

8.  Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

Authors:  S Yeh; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate.

Authors:  D B Lubahn; D R Joseph; M Sar; J Tan; H N Higgs; R E Larson; F S French; E M Wilson
Journal:  Mol Endocrinol       Date:  1988-12

10.  The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity.

Authors:  M Zerial; L Toschi; R P Ryseck; M Schuermann; R Müller; R Bravo
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

View more
  12 in total

Review 1.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

2.  MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Maya Datt Joshi; Minakshi Guha; Maroof Alam; Surender Kharbanda; Donald Kufe
Journal:  Prostate       Date:  2012-04-02       Impact factor: 4.104

3.  Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.

Authors:  Liang-Nian Song; Roger Herrell; Stephen Byers; Salimuddin Shah; Elizabeth M Wilson; Edward P Gelmann
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

4.  Mitogen-activated protein kinase kinase kinase 1 activates androgen receptor-dependent transcription and apoptosis in prostate cancer.

Authors:  M T Abreu-Martin; A Chari; A A Palladino; N A Craft; C L Sawyers
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

5.  Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.

Authors:  Stanislav Zelivianski; Richard Glowacki; Ming-Fong Lin
Journal:  Nucleic Acids Res       Date:  2004-07-07       Impact factor: 16.971

6.  Spongian diterpenoids inhibit androgen receptor activity.

Authors:  Yu Chi Yang; Labros G Meimetis; Amy H Tien; Nasrin R Mawji; Gavin Carr; Jun Wang; Raymond J Andersen; Marianne D Sadar
Journal:  Mol Cancer Ther       Date:  2013-02-26       Impact factor: 6.261

7.  Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

Authors:  Qianben Wang; Wei Li; Yong Zhang; Xin Yuan; Kexin Xu; Jindan Yu; Zhong Chen; Rameen Beroukhim; Hongyun Wang; Mathieu Lupien; Tao Wu; Meredith M Regan; Clifford A Meyer; Jason S Carroll; Arjun Kumar Manrai; Olli A Jänne; Steven P Balk; Rohit Mehra; Bo Han; Arul M Chinnaiyan; Mark A Rubin; Lawrence True; Michelangelo Fiorentino; Christopher Fiore; Massimo Loda; Philip W Kantoff; X Shirley Liu; Myles Brown
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

8.  Target analysis by integration of transcriptome and ChIP-seq data with BETA.

Authors:  Su Wang; Hanfei Sun; Jian Ma; Chongzhi Zang; Chenfei Wang; Juan Wang; Qianzi Tang; Clifford A Meyer; Yong Zhang; X Shirley Liu
Journal:  Nat Protoc       Date:  2013-11-21       Impact factor: 13.491

9.  Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth.

Authors:  Chih-Rong Shyr; Meng-Yin Tsai; Shuyuan Yeh; Hong-Yo Kang; Yun-Chao Chang; Pei-Ling Wong; Chao-Cheng Huang; Ko-En Huang; Chawnshang Chang
Journal:  Prostate       Date:  2010-02-01       Impact factor: 4.104

10.  Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.

Authors:  Kevin A Link; Sucharitha Balasubramaniam; Ankur Sharma; Clay E S Comstock; Sonia Godoy-Tundidor; Nathan Powers; Khanh H Cao; Annemie Haelens; Frank Claessens; Monica P Revelo; Karen E Knudsen
Journal:  Cancer Res       Date:  2008-06-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.